Anterix: Spectrum Monopoly at 89% Discount, but Execution Risk Persists

What happened

Anterix holds a de facto monopoly on 900 MHz broadband spectrum, valued by management at $2.5-$7 billion, yet trades at a $758 million market cap, implying a significant discount. Recent FCC expansion to 10 MHz and a Qualcomm partnership unlock new consumer and satellite opportunities, expanding the addressable market beyond utilities. Growing strategic interest, exemplified by Amazon's $11.57 billion Globalstar acquisition and an ongoing Morgan Stanley-led strategic review, could lead to a premium buyout. However, the DeepValue report flags slow commercialization: core spectrum revenue was only $1.6M in Q2 FY26, operating cash flow remains negative, and liquidity is thin at $39M cash against $114M contracted proceeds. The bull case depends on converting a $3B pipeline into contracts and achieving positive cash flow, but the current price already discounts execution risks, warranting a wait-and-see approach.

Implication

The market is pricing in a discounted spectrum asset but ignoring the risk that pipeline conversion may stall. Near-term catalysts include the strategic review outcome and FY26 cash receipts guidance. Anterix could be a 3-5x return if utility adoption accelerates or a buyout materializes. However, without incremental large contracts or solutions revenue, the stock may remain range-bound or decline. The current WAIT rating with attractive entry around $18 provides a margin of safety, while upside above $32 suggests trimming.

Thesis delta

The previous thesis acknowledged the asset value but emphasized waiting for monetization proof. The new article adds bullish external validation (FCC expansion, Amazon deal) that could accelerate a strategic transaction. This shifts the skew slightly toward the bull case, but the fundamental execution uncertainty remains unchanged. Therefore, the thesis is maintained: wait for clearer contract wins or a formal bid before committing capital.